Epidemiology of Tumor-Induced Osteomalacia in Germany Based on Real World Data
Calcified Tissue International · 2023
DOI: 10.1007/s00223-023-01148-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Calcified Tissue International, 2023. Verfasst von Melanie May und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Payer Value & Patient Access, Kyowa Kirin GmbH, Monschauer Str. 1, 40549, Duesseldorf, Germany. Melanie.May@kyowakirin.com. Hauptthemen laut MEDLINE: Osteomalacia, Delayed Diagnosis. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Kyowa Kirin.
Abstract (Originalsprache)
Tumor-induced osteomalacia (TIO) is an ultra-rare disease caused mostly by benign tumors that secrete fibroblast growth factor-23. Because of nonspecific symptoms, the diagnostic delay is long, and therapy can be challenging. Moreover, epidemiological data on TIO are scarce owing to its rarity. Therefore, this study aimed to quantify TIO’s incidence rates and prevalence in Germany. Retrospective longitudinal and cross-sectional analyses were conducted using anonymized German claims data from the statutory health insurance (SHI) database. This database, which comprises the data of approximately 5 million insurants, is a representative sample of the German population and supports national projections. As there is no unique International Statistical Classification of Diseases and Related Health Problems (ICD) code for TIO, operational categories based on different surrogates were defined to determine the prevalence and incidence rates of TIO among probable patients. This study showed that TIO has a prevalence of (documented code, advanced imaging, medication, or tumor removal) 0.187 per 100,000 persons and an incidence rate of ≤ 0.094 per 100,000 person years. This analysis provides the first epidemiological insight into German patients with TIO. Despite the general limitations associated with the analysis of SHI claims data of ultra-rare diseases, we believe that this analysis provides a sound basis for further analysis, particularly with regard to the care situation of patients with TIO.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Payer Value & Patient Access, Kyowa Kirin GmbH, Monschauer Str. 1, 40549, Duesseldorf, Germany. Melanie.May@kyowakirin.com.
- Department of Osteology and Biomechanics, University Hospital Hamburg-Eppendorf (UKE), Lottestraße 59, 22529, Hamburg, Germany.
- InGef - Institute for Applied Health Research Berlin GmbH, InGef, Otto-Ostrowski-Straße 5, 10249, Berlin, Germany.
- Department of Payer Value & Patient Access, Kyowa Kirin GmbH, Monschauer Str. 1, 40549, Duesseldorf, Germany.
- Department of Franchise Nephrology, Kyowa Kirin GmbH, Monschauer Str. 1, 40549, Duesseldorf, Germany.
- Hochschule Niederrhein, University of Applied Sciences, Competence Center Routine Data, Reinarzstraße 49, 47805, Krefeld, Germany.
ORCID-Profile: Melanie May
Förderung
- Kyowa Kirin
Zitieren
APA
May, M., Oheim, R., Bovy, L., Doess, A., Maessen, D., Neukirch, B., Norris, R., Williams, A., & Abrahamsen, B. (2023). Epidemiology of Tumor-Induced Osteomalacia in Germany Based on Real World Data. Calcified Tissue International. https://doi.org/10.1007/s00223-023-01148-2
Vancouver
May M, Oheim R, Bovy L, Doess A, Maessen D, Neukirch B, et al. Epidemiology of Tumor-Induced Osteomalacia in Germany Based on Real World Data. Calcified Tissue International. 2023. doi:10.1007/s00223-023-01148-2
BibTeX
@article{May2023,
author = {May, Melanie and Oheim, Ralf and Bovy, Leonore and Doess, Axel and Maessen, Dirk and Neukirch, Benno and Norris, Raeleesha and Williams, Angela and Abrahamsen, Bo},
title = {Epidemiology of Tumor-Induced Osteomalacia in Germany Based on Real World Data},
journal = {Calcified Tissue International},
year = {2023},
doi = {10.1007/s00223-023-01148-2}
}
EUVIMED